Francis Sheila E
Department of Cardiovascular Science, Medical School, University of Sheffield, Sheffield, United Kingdom.
Prog Mol Biol Transl Sci. 2014;124:1-18. doi: 10.1016/B978-0-12-386930-2.00001-X.
Atherosclerosis is a pathological process with several inputs (biological, chemical, physiological, and others) interacting slowly over a lifetime leading to coronary artery disease, significant morbidity, and a limited lifespan. Over the past two decades, biologists have used experimental preparations from cells, animals, and man to understand the biology of atherosclerosis. Much has been discovered but our use of the standard gene-targeted experimental preparations is now nearing its limit. Better preparations to answer the remaining questions in the field of atherosclerosis biology are needed.
动脉粥样硬化是一种病理过程,有多种因素(生物学、化学、生理学等)在一生中缓慢相互作用,导致冠状动脉疾病、高发病率和有限的寿命。在过去二十年中,生物学家利用细胞、动物和人类的实验制剂来了解动脉粥样硬化的生物学机制。已经发现了很多,但我们对标准基因靶向实验制剂的使用现在已接近极限。需要更好的制剂来回答动脉粥样硬化生物学领域的剩余问题。